# TERLIVAZ
> **NDA022231** · New Drug Application · Sponsor: MALLINCKRODT IRELAND · Approved 2022-09-14
## Drug
- **FDA Application Number:** NDA022231
- **Application type:** New Drug Application
- **Brand name:** TERLIVAZ
- **Generic name:** TERLIPRESSIN
- **Active ingredients:** TERLIPRESSIN ACETATE
- **Dosage form:** POWDER
- **Route:** INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** MALLINCKRODT IRELAND
- **Manufacturer:** Mallinckrodt Hospital Products Inc.
- **First approval:** 2022-09-14
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022231)
---
*MORVS · CC0 1.0*